Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
404.700
+5.370
+1.34%
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…
CLAIM SALE
Ubs (lux) Equity Fund - Greater China (usd) P-acc (0P00000AXX)
Add to/Remove from a Portfolio
Add to Watchlist
27/11 - Closed. Currency in USD
- Morningstar Rating:
- Total Assets: 602.82M
Type:
Fund
Market:
Luxembourg
Issuer:
UBS Fund Management (Luxembourg) S.A.
ISIN:
LU0072913022
Asset Class:
Equity
UBS Lux Equity Fund - Greater China USD P-acc
404.700
+5.370
+1.34%
- General
- Chart
- News & Analysis
- Technical
- Forum
- Overview
- Profile
- Historical Data
- Holdings
0P00000AXX Overview
On this page you'll find an in-depth profile of Ubs (lux) Equity Fund - Greater China (usd) P-acc. Learn about the key management, total assets, investment strategy and contact information of 0P00000AXX among other information.
Investment Strategy
The Fund’s investment objective consists in generating strong capital appreciation with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. The sub-fund invests mainly in shares and other equity interests of companies domiciled in the People’s Republic of China or Taiwan as well as in other companies domiciled in East Asia that have close economic links with the People’s Republic of China or Taiwan. Investors should note that the sub-fund’s exposure may also include Chinese A shares traded via Shanghai-Hong Kong Stock Connect or Shenzhen-Hong Kong Stock Connect. Chinese A shares are renminbi-denominated A shares of companies domiciled in mainland China; these are traded on Chinese stock exchanges such as the Shanghai Stock Exchange and the Shenzhen Stock Exchange.
Contact Information
Address
5, rue Jean Monnet
Luxembourg,* L-2180
Luxembourg
Luxembourg,* L-2180
Luxembourg
Phone
+352 4 36 16 11
Fax
+352 4 36 16 1555
Top Executives
| Name | Title | Since | Until |
|---|---|---|---|
| Morris Wu | Research Analyst | 2019 | Now |
| Biography | Morris is a member of the Global Emerging Markets and Asia Pacific Equities team and is responsible for investment analysis of China/Hong Kong equities. Morris joined UBS Global Asset Management in May 2015. Prior to this, he was a consulting director at BDA China, providing investment advisory services to top tier hedge funds and private equity funds for their investments in China. Morris worked at BDA for 9 years and specialized in the Consumer and TMT sectors. | ||
| Denise Cheung | - | 2018 | Now |
| Bin Shi | Portfolio Manager | 2015 | Now |
| Biography | Bin Shi is a member of the Global Emerging Market and Asia Pacific Equities team, located in Hong Kong. He is Country Analyst and Portfolio Manager for China with a focus on Chinese stocks listed on both the overseas and domestic Chinese stock exchanges. Prior to joining UBS Asset Management, Bin spent three years as Head of Int’l Business, portfolio manager and analyst with Boshi Fund Management Co., one of the largest domestic mutual fund companies in China. Prior to that, he worked in the US for eight years as portfolio manager and analyst for several US mutual fund firms. Bin joined UBS in January 2006 and has managed the Greater China Fund since April 2006. | ||
| Yu Zhang | - | 2018 | 2019 |
| Derrick Sun | - | 2018 | 2018 |
| Biography | Derrick Sun is a member of the Global Emerging Markets and Asian Pacific Equities team and is responsible for investment analysis of China/Hong Kong Equities. Derrick joined UBS Asset Management in July 2013. Prior to this, he was head of research for healthcare and small & mid-cap with Bank of China International (BOCI) and BNP Paribas. Previous industry experience includes 5 years managing a bio-pharmaceutical company’s Shanghai subsidiary and 5 years in Deloitte Consulting (US) where he provided business consulting services to Fortune 500 healthcare and consumer companies. | ||
| Projit Chatterjee | - | 2006 | 2018 |
| Biography | Projit Chatterjee is a Senior Equity Specialist within the Global Emerging Markets and Asia Pacific Equities team at UBS Asset Management, based in Singapore. He is also a member of the Global Emerging Markets Strategy Committee and co-manager of the GEM High Dividend funds. Projit has primary responsibility for overall product positioning and development of Emerging Markets and Asian Equity strategies, as well as marketing and communication of these strategies to existing and prospective clients globally. Projit joined UBS in 1997 as a Corporate Finance Analyst with UBS Investment Bank in Mumbai, India. In 1999, he moved to UBS Asset Management in Zurich to work in Strategic Projects, International Fund Marketing. In Zurich, Projit held various roles in the areas of strategic business development, business management and investment solutions. He also led an acquisition project in the Indian market. Before joining UBS, Projit worked as a money market and foreign exchange dealer in the treasury of MashreqBank, a UAE bank in Mumbai. | ||
| Hai Huang | - | 2010 | 2015 |
Write your thoughts about Ubs (lux) Equity Fund - Greater China (usd) P-acc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review